Group Metacognitive Therapy

What is GROUP Metacognitive Therapy (MCT)?

Metacognitive Therapy was developed by Professor Adrian Wells. It directly reduces worry, rumination and unhelpful thinking styles and modifies the specific beliefs behind them.

It is a psychological treatment that helps people to manage worries and low mood through reducing unhelpful styles of thinking and has been shown to alleviate depression and anxiety in mental health settings.

Extensive evidence shows that a particular style of thinking dominated by rumination (dwelling on the past) and worry (concerns about the future) maintains emotional distress.

Metacognitive therapy helps people to discover new and more helpful ways to react to negative or distressing thoughts so they are less likely to dwell on them, resulting in a positive effect on anxiety and mood.

As part of the PATHWAY trial we delivered metacognitive therapy in a group of 3-10 patients. Patients received six sessions that lasted 60 minutes. 

Sessions were delivered by a trained health professional from cardiac rehabilitation services, this includes nurses, physiotherapists, and occupational therapists.

IS METACOGNITIVE THERAPY EFFECTIVE AT REDUCING ANXIETY/DEPRESSION IN CARDIAC PATIENTS? 

Yes it is! Watch our video to find out more about how group-MCT is effective at treating anxiety and depression in cardiac rehabilitation patients

PATHWAY is funded by the National Institute for Health Research (NIHR).

This website presents independent research funded by the National Institute for Health Research under its Program Grants for Applied Research Program (grant No. RP-PG-1211-20011). The views expressed are those of the author(s) and not necessarily those of the National Institute for Health Research or the Department of Health.